COVID-19: Don’t let the guard down, caution experts
If caution is thrown to the wind, we could well be laying out an invitation for a second wave, which the country can ill afford. (PTI Photo/File) If there are…
COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert
Almost all the major platforms to make the vaccines are being carried out in India by at least half a dozen leading Indian vaccine companies and many smaller companies. (AP…
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective…
Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies vaccine roll out
In the space for glass vials needed for the vaccines, companies have been expanding capacities and ramping up supplies. (AP image/Representational picture)Deliverance in the new year will come encased in…
Covid-19 vaccination: Can’t deny chances of an adverse event, states told to be prepared, says health secretary
India's Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan avered, adding that India's CFR is among the lowest in the world. (Representational…
Coronavirus: Who gets Covid-19 vaccine first in India? Prevent disease or check transmission, asks Dr Kang
Coronavirus vaccine update: However, if the central government wants to "prevent transmission" then younger, working-age populations, who will be interacting more with others, should be vaccinated. (Reuters image)Coronavirus vaccine in…
Coronavirus Vaccine: US-based Moderna’s COVID-19 vaccine shows similar effectiveness among old, young age groups
Results of Moderna’s vaccine have so far shown that older people were found to be more vulnerable to the highly contagious disease. (Reuters image)Coronavirus update, COVID19 vaccine tracker: US-based Moderna’s…
Health ministry recommends COVID tests for all tuberculosis patients and vice versa
The prevalence of tuberculosis among COVID-19 patients has been found to be 0.37 to 4.47 per cent in different studies, the ministry said. (Representational image)Tuberculosis is associated with a 2.1-fold…
Does COVID-19 vaccine have similar immune response in old and young? Here’s what Moderna’s trials show
Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people. (Representational…
Reason behind rise in Covid cases? Coronavirus re-infections raise concerns about immunity
Some experts say it is likely that such cases are starting to emerge because of greater testing worldwide, rather than because the virus may be spreading differently. (Representational image)Two European…